Conference Policies


On This Page:

Photo/Video/Audio Recording Policy

Audio and video recording are prohibited.

Photographs: Please respect speaker instructions in regards to the taking of photos during their presentation. Do not capture or share details of any unpublished data presented at the meeting.

If a speaker has indicated that they are open to photography, please use common courtesy and do not behave in a manner that is disruptive or distracting, either to the speaker or to your fellow audience members.

Because of the proprietary nature of data and the reporting of preliminary, unpublished research findings, the dissemination or reproduction of someone else’s slides, poster(s), audio or data before, during or after AAIC is strictly prohibited.

Sharing your experience on social media is encouraged to add to the discussion and excitement of AAIC, as long as it complies with AAIC embargo and confidentiality rules. Sharing of images on social media that contain discernable research data is prohibited.

Violation of the above restrictions may result in appropriate penalty, including removal from AAIC, and denial of entry to future AAICs.

Please direct questions regarding this policy to

Credentialed reporters should register with the Alzheimer’s Association media relations department, and follow the policies outlined by AAIC media relations guidelines published on the AAIC website.

Conference News Embargo Policy

The Alzheimer's Association International Conference (AAIC) is a well-recognized, global platform for news regarding advances in Alzheimer's and dementia research. If you are interested in having the research you present at AAIC eligible for inclusion in AAIC news releases and news conferences, it must not be published (online or hard copy) or presented, in whole or in part, in any manner, previous to presentation at AAIC. (Note: The Association reserves the right to also include previously published material in its news program, if it so chooses, but this is generally not the case.)

All materials submitted to AAIC are embargoed for publication and broadcast until the officially scheduled date and time of presentation at AAIC, unless the Alzheimer's Association provides written notice of change of date and/or time in advance, such as on an AAIC news release. If there are questions, please contact the Alzheimer’s Association Public Relations Department at

All news media representatives, scientists, funders of science presented at AAIC, and AAIC exhibitors/sponsors agree to be bound by the AAIC news embargoes laid out in this policy, in addition to release times stated on news releases and other news materials issued by the Alzheimer’s Association and AAIC.

Public and news announcements made in advance of AAIC that a scientist or company is scheduled to make a presentation at AAIC may include the date, time, location and topic of presentation, but may not include the methods, results and/or conclusions, nor the type or direction of results, even if that is included in the name/title of the submitted abstract. For that reason, authors are discouraged from putting the type and/or direction of results in the abstract title.

All news media representatives, scientists and their funders, and exhibitors/sponsors agree to honor the news embargoes and release times stated on news releases and other news materials issued by the Alzheimer's Association/AAIC. If a reporter or news media outlet breaks an AAIC news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events.

If a scientist or company that is a participant in an AAIC news briefing or news release is discovered to have broken the news embargo, or encouraged the breaking of a news embargo, the Alzheimer's Association reserves the right to remove the participant from the news briefing and remove that scientist's/company's information from the news release. In addition, consequences for violation of the news embargo may include retraction of the accepted abstract from AAIC and/or loss of privileges of presenting research at AAIC in the future.

SEC-Related Issues

If a publicly traded company is advised that it is legally required to disclose certain data or other information from a confidential AAIC abstract in advance of the AAIC news embargo to satisfy requirements of the U.S. Securities and Exchange Commission or a corresponding regulatory body in a country where the company’s stock is traded (collectively, “SEC”), that company must submit to AAIC, in advance of the SEC-required disclosure:

If this is done, the abstract will not be automatically rejected or removed from AAIC on the basis of the SEC-required release of data or other information, though the situation is still subject to AAIC review. At a minimum, AAIC may in its discretion change the position of the abstract in AAIC, e.g., from oral presentation to poster. The abstract will most likely be ineligible for the AAIC news program.

The company may issue a news release at the time of SEC-required disclosure. The AAIC abstract itself may not be released publicly by the company or lead author. Mention may be made that full details will be presented at AAIC. AAIC would prefer that the news release:

As an example, a statement that a study “met its primary endpoint of improving cognition” is qualitative, while “ADAS-Cog scores remained stable for 18 months in the treated group” would be considered quantitative. A quote such as “We are encouraged by these promising results” would not be viewed as interpretive, while a quote such as “These findings support [drug] as first line therapy in mild to moderate Alzheimer’s” would be seen as an interpretation of the data.

Become an ISTAART Member

Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


Join the Conversation #AAIC22






News & Videos

Press Room

Contact Us

> 1200px
> 992px
> 768px
< 767px